Core Viewpoint - Four Corners Property Trust (FCPT) reported quarterly funds from operations (FFO) of $0.45 per share, matching the Zacks Consensus Estimate and showing a slight increase from $0.44 per share a year ago [1] Financial Performance - The company posted revenues of $75.67 million for the quarter ended December 2025, which was 0.1% below the Zacks Consensus Estimate and an increase from $68.34 million year-over-year [2] - Over the last four quarters, FCPT has not surpassed consensus FFO or revenue estimates [2] Stock Performance - FCPT shares have increased approximately 9.9% since the beginning of the year, outperforming the S&P 500's gain of 1.4% [3] - The stock's immediate price movement will depend on management's commentary during the earnings call [3] Future Outlook - The current consensus FFO estimate for the upcoming quarter is $0.45 on revenues of $77.3 million, and for the current fiscal year, it is $1.85 on revenues of $317.44 million [7] - The estimate revisions trend for FCPT was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The REIT and Equity Trust - Other industry is currently ranked in the bottom 29% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8]

Agree Realty (ADC) came out with quarterly funds from operations (FFO) of $1.11 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to FFO of $1.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +1.21%. A quarter ago, it was expected that this real estate investment trust would post FFO of $1.08 per share when it actually produced FFO of $1.1, delivering a surprise of +1.85%.Over the last four quarters ...

W.P. Carey (WPC) came out with quarterly funds from operations (FFO) of $1.27 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to FFO of $1.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an FFO surprise of +1.06%. A quarter ago, it was expected that this real estate investment trust would post FFO of $1.23 per share when it actually produced FFO of $1.25, delivering a surprise of +1.63%.Over the last four quarters ...

分组1 - InvenTrust Properties Corp. reported quarterly funds from operations (FFO) of $0.46 per share, exceeding the Zacks Consensus Estimate of $0.45 per share, and up from $0.43 per share a year ago, representing an FFO surprise of +3.37% [1] - The company achieved revenues of $77.38 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.09%, compared to $71.23 million in the same quarter last year [2] - InvenTrust Properties has outperformed the S&P 500, with shares increasing by approximately 7.2% since the beginning of the year, while the S&P 500 gained 1.7% [3] 分组2 - The current consensus FFO estimate for the upcoming quarter is $0.47 on revenues of $74.01 million, and for the current fiscal year, it is $1.91 on revenues of $301.42 million [7] - The Zacks Industry Rank indicates that the REIT and Equity Trust - Other sector is currently in the bottom 27% of over 250 Zacks industries, suggesting potential challenges for stocks in this category [8] - The estimate revisions trend for InvenTrust Properties was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6]

分组1 - First Industrial Realty Trust reported quarterly funds from operations (FFO) of $0.77 per share, exceeding the Zacks Consensus Estimate of $0.76 per share, and up from $0.71 per share a year ago, representing an FFO surprise of +1.24% [1] - The company posted revenues of $188.41 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.37%, compared to year-ago revenues of $175.59 million [2] - The stock has gained approximately 1.8% since the beginning of the year, outperforming the S&P 500's gain of 1.1% [3] 分组2 - The current consensus FFO estimate for the coming quarter is $0.72 on revenues of $188.58 million, and for the current fiscal year, it is $3.15 on revenues of $772.55 million [7] - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the bottom 28% of over 250 Zacks industries, indicating potential challenges for the sector [8] - The estimate revisions trend for First Industrial Realty Trust was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, suggesting expected outperformance in the near future [6]

Core Viewpoint - Equity Lifestyle Properties (ELS) reported quarterly funds from operations (FFO) of $0.79 per share, exceeding the Zacks Consensus Estimate of $0.78 per share, and showing an increase from $0.76 per share a year ago, indicating a positive performance trend [1] Financial Performance - The company achieved revenues of $373.87 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.16% and showing a slight increase from $372.32 million year-over-year [2] - Over the last four quarters, ELS has only surpassed consensus FFO estimates once [2] Stock Performance - ELS shares have increased approximately 3.8% since the beginning of the year, outperforming the S&P 500, which gained 1.9% [3] Future Outlook - The future performance of ELS stock will largely depend on management's commentary during the earnings call and the company's FFO outlook for upcoming quarters [4][6] - The current consensus FFO estimate for the next quarter is $0.83 on revenues of $391.43 million, and for the current fiscal year, it is $3.18 on revenues of $1.6 billion [7] Industry Context - The REIT and Equity Trust - Residential industry, to which ELS belongs, is currently ranked in the bottom 36% of over 250 Zacks industries, indicating potential challenges ahead [8]

Company Performance - CRISPR Therapeutics AG closed at $54.21, reflecting a -4.71% change from the previous day, underperforming compared to the S&P 500's daily gain of 0.26% [1] - Prior to the recent trading session, the company's shares had increased by 3.93%, surpassing the Medical sector's gain of 0.92% and the S&P 500's gain of 1.57% [1] Earnings Forecast - The upcoming earnings disclosure is expected to show an EPS of -$1.15, indicating a significant 161.36% decline from the same quarter last year [2] - Revenue is forecasted at $4 million, representing an 88.78% decrease compared to the same quarter last year [2] - For the full year, the Zacks Consensus Estimates predict an EPS of -$6.33 and revenue of $8.54 million, reflecting changes of -45.85% and 0% respectively from the prior year [3] Analyst Estimates and Rankings - Changes in analyst estimates for CRISPR Therapeutics AG are crucial as they reflect short-term business trends, with positive revisions indicating a favorable outlook on business health and profitability [4] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has shown a strong track record, with stocks rated 1 achieving an average annual return of +25% since 1988 [6] - Currently, CRISPR Therapeutics AG holds a Zacks Rank of 3 (Hold), with the consensus EPS estimate having increased by 0.17% over the past month [6] Industry Overview - The Medical - Biomedical and Genetics industry, which includes CRISPR Therapeutics AG, has a Zacks Industry Rank of 100, placing it in the top 41% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

分组1 - American Healthcare REIT (AHR) reported quarterly funds from operations (FFO) of $0.44 per share, exceeding the Zacks Consensus Estimate of $0.42 per share, and up from $0.36 per share a year ago, representing an FFO surprise of +4.76% [1] - The company posted revenues of $572.94 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.36%, compared to year-ago revenues of $523.81 million [2] - American Healthcare REIT shares have increased approximately 65.7% since the beginning of the year, significantly outperforming the S&P 500's gain of 15.6% [3] 分组2 - The future performance of American Healthcare REIT's stock will largely depend on management's commentary during the earnings call and the outlook for FFO [3][4] - The current consensus FFO estimate for the upcoming quarter is $0.44 on revenues of $592.53 million, and for the current fiscal year, it is $1.67 on revenues of $2.24 billion [7] - The Zacks Industry Rank indicates that the REIT and Equity Trust - Other sector is currently in the top 30% of over 250 Zacks industries, suggesting a favorable outlook for stocks in this category [8]

分组1 - Service Properties (SVC) reported quarterly funds from operations (FFO) of $0.2 per share, missing the Zacks Consensus Estimate of $0.21 per share, and down from $0.32 per share a year ago, representing an FFO surprise of -4.76% [1] - The company posted revenues of $478.77 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 1.86%, and down from $491.17 million year-over-year [2] - Service Properties has surpassed consensus FFO estimates three times over the last four quarters, but has underperformed the market with shares losing about 22.4% since the beginning of the year [2][3] 分组2 - The current consensus FFO estimate for the coming quarter is $0.13 on revenues of $457.11 million, and for the current fiscal year, it is $0.74 on revenues of $1.88 billion [7] - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Financial Performance - Sabra Healthcare reported quarterly funds from operations (FFO) of $0.38 per share, matching the Zacks Consensus Estimate and showing an increase from $0.37 per share a year ago [1] - The company posted revenues of $190.04 million for the quarter ended September 2025, which was 1.08% below the Zacks Consensus Estimate, compared to $178 million in the same quarter last year [2] - Over the last four quarters, Sabra has surpassed consensus FFO estimates two times and topped consensus revenue estimates two times [2] Stock Performance and Outlook - Sabra shares have increased by approximately 3.8% since the beginning of the year, while the S&P 500 has gained 15.1% [3] - The future stock price movement will largely depend on management's commentary during the earnings call and the company's FFO outlook [3][4] - The current consensus FFO estimate for the upcoming quarter is $0.38 on revenues of $195.79 million, and for the current fiscal year, it is $1.50 on revenues of $760.6 million [7] Industry Context - The REIT and Equity Trust - Other industry, to which Sabra belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in estimate revisions, which can impact Sabra's stock performance [5][6]